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The last century has been largely driven by wealth of natural resources; however, more than ever 
before, knowledge, skills and intellectualism are now the driving force of current global wealth creation. 
The demonstration of this fact can be found with nations that have advanced their science and 
technology system and have adopted new technologies. Knowledge of space science, information 
technology and biotechnology in particular are been explored to narrow the divide between ‘have’ and 
‘have not’ in these communities. The application of biotechnology is not new, it has been employed for 
centuries in the production of fermented foods such as gari, bread, beer, yoghurt, cheese and 
beverages such as wine. Modern advances in biotechnology hold great promise for addressing key 
challenges in agriculture, human health and the environment. Biotechnology, as with any new 
technology has its advantages and limitations; the application of modern biotechnology has 
highlighted its positive impact on agriculture, human health and the environment through increased 
crop yields, the reduced use of pesticides and herbicides, production of nutritionally enhanced foods 
and affordable vaccines. It is indeed an essential panacea to the pervasive poverty and food security 
problem in Nigeria. The debate about biotechnology continues because of, politics, trade and ethical 
issues that have been raised in the public domain with little distinction  being made between 
biotechnology as a tool and genetically modified (GM) crops and foods as products, leading to the 
intense controversy about the perceived risks to human health and environment. This highlights the 
importance of having biosafety regulations in place and ensuring that there is adequate in-country 
capacity so that all the necessary precautions are adhered to. The debate must shift to how this 
technology can be adopted and deployed to benefit the nation and its citizens in such a way that the 
ecosystem is not threatened. 
 





Africa is endowed with natural resources possessing market 
potentials. In the absence of market segmentation, the 
Sub-Saharan Africa region will be the third largest single 
market in the world, after China and India with a population 
approaching the billion mark, which offers tremendous 
opportunities for economies of scale. The latest statistics 
indicate that Sub-Saharan Africa is the only region of the 
world where poverty increased during the last decade 
and projections are not encouraging either. By 2015, the 
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50% of the world’s extremely poor population, those living 
on less than a dollar a day. The recent International Fund 
for Agricultural Development report (IFAD) makes a 
strong case that the effective use of biotechnology will be 
essential to the alleviation of rural poverty in developing 
countries. Biotechnology is now being heralded as the 
technology for the future and promises are already being 
made that this new technology will solve the problem of 
world hunger as it revolutionizes agriculture.  
The application of biotechnology (traditional biotech) is 
not new, it has been employed for centuries in the 
production of fermented foods such as gari, bread, beer, 
yoghurt, cheese and beverages such as wine. Modern 
advances in biotechnology hold great promise for 
addressing key challenges  in  agriculture,  human  health   




and the environment. The Convention on Biological 
Diversity (2000) defines biotechnology as “any technolo-
gical application that uses biological systems, living 
organisms, or derivatives to make or modify products or 
processes for specific use”. 
Biotechnology as with any new technology has its 
advantages and limitations. The application of modern 
biotechnology has highlighted its positive impact on 
agriculture, human health and the environment through 
increased crop yields, the reduced use of pesticides and 
herbicides, production of nutritionally enhanced foods 
and affordable vaccines. The debate about biotechnology 
continues as political, trade and ethical issues that have 
been raised in the public domain has made little distinction 
between biotechnology as a tool and genetically modified 
(GM) crops and foods as products, leading to the intense 
controversy about the perceived risks to human health 
and environment. Despite scientific evidence, associated 
risks are continuously debated. There is however a 
consensus on the need for effective and continuous 
monitoring, assessment and management of the potential 
risks. This highlights the importance of having biosafety 
regulations in place and ensuring that there is adequate 
in-country capacity so that all the necessary precautions 
are adhered to (Wambugu, 1999).  
Taking cognizance of the different applications of 
biotechnology in the environment, food and agriculture, 
healthcare and the industrial sectors, it is indeed an 
essential panacea to the pervasive poverty and food 
security problem in Nigeria. Though biotechnology is not 
the only solution to these challenges, it is an essential 
tool that cannot be ignored. Thus, policy makers and 
scientists need to urgently identify specific areas of 
interest to address peculiar problems and the debate 
should be shifted to the nature of innovative policies and 
laws to regulate the adoption and deployment of this 
technology in such a way that both the end-user and the 




APPLICATION IN FOOD AND AGRICULTURE 
 
By the early 1980s, it became apparent that the agricultural 
sector could no longer meet the domestic food require-
ments. Agricultural production has stagnated at less than 
1% annual growth rate with the population growth rate 
between 2.5 - 3% per annum; thus, domestic food supply 
had to be augmented through large imports. The food 
import bill rose from a mere 14112.88 million naira 
annually during 1970-74 to N1, 964.8 million naira in 
1991 (Talabi and onasanya, 2004).  
The conventional breeding process being the basis for 
development of essentially all varieties of plants used in 
African agriculture today is slow, commonly requiring 10 
years before a new variety can be released. One of the 
biggest problems with this process is that desirable 





may not be found among any of the plants of that species 
hence a dead end for the transfer of the desired trait is 
reached. Genetic engineering more than any other 
technology has the potential to address these challenges 
at the same time introducing cultivars traits from an 
unlimited gene pool. So far, most of the plants that have 
been genetically engineered have been for crops with 
single gene alteration that confers agronomic benefits like 
resistance to pest or herbicides. By 2005, the acreage for 
genetically engineered (GE) crops was estimated to be 
222 million acres worldwide, and the number of countries 
growing such crops had reached 23 in the same year, 
however most of the acreages are mainly concentrated 
among four crops (soybeans, corn, cotton and canola) 
and five countries. The United States accounts for 55% of 
global acreage, Argentina had 19%, Brazil (10%), 
Canada (7%) and China (4%) (ISAAA, 2005). The African 
continent more than any other needs to adopt the 
application of biotechnology and transgenic crops to its 
Agricultural system for it to be able to feed its teeming 
population on the current cultivated area with reduced 
environmental impact. The yield gains from GM crops 
has made it possible for the world’s farmers to double 
global food harvest in the last 50 years on roughly the 
same amount of land at a time when global population 
increased by more than 80% between 1996 -2006; China 
had an enhanced income of US$5.8 billion from Bt 
cotton; in 2006 alone it earned US$817 million (James, 
1998). Some modest achievements are been made in 
Nigeria and should be commended, particularly the 
current effort between the Institute for Agricultural 
Research (IAR) Zaria and African Agricultural Technology 
Foundation (AATF) Kenya on maruca resistance cowpea/ 
bean. Maruca (caterpillar of a butterfly) attack is the 
biggest problem of cowpea accounting for over 30% loss 
of this crop; National Biotechnology Development Agency 
(NABDA) is committed to this project by supporting the 
construction of a level -2 containment facility. Also NABDA 
is also establishing state of the art tissue culture facility 
across the country for the development of in vitro micro 
propagation of endangered, underutilized exotic and 
indigenous plant species. NABDA is an institutional organ 
of government responsible for the promotion, coordina-
tion and deployment of biotechnology in Nigeria. 
 
 
APPLICATION IN ENVIRONMENT 
 
The environment embraces the three levels of life forms 
on the earth namely the genetic diversity within the 
species which is the functional unit of heredity in plant, 
the diversity of species both wild and domesticated within 
a geographic area and the diversity of habitats and 
ecosystem for diverse species around the world. These 
are today being threatened by the activities of man. It has 
become clear that the old method of dumping industrial, 
military and agricultural chemicals into waterways or 





term effect and damage to the environment as well as to 
human health. Today biotechnology as a tool is providing 
newer, more efficient clean up techniques and at the 
same time wealth is generated from what ordinary would 
have been considered as waste. The US Environmental 
Protection Agency reported that several million tons of 
hazardous waste was generated in the 1970’s and using 
conventional clean up techniques, geological survey 
estimated that up to a trillion dollars will be required to 
clear the backlog of the polluted sites. 
 
 
APPLICATION IN HEALTH AND DRUG 
DEVELOPMENT 
 
Biotechnology has heralded in a new era in prevention, 
diagnostics and therapeutics of diseases and infections. 
Molecular mechanisms of disease are now better 
understood, diagnostic methods improved, therapeutic 
modalities increased; safer and more effective vaccines 
developed. Research is directed towards developing new 
kinds of improved vaccines (polysaccharide-protein 
conjugates, immunogenic proteins) for preventing bacterial 
diseases. Another high priority is the development of 
genetically engineered vaccines against human immuno-
deficiency virus (HIV), hepatitis A and C and other 
viruses. The use of biosensors to measure metabolites, 
enzymes and other cellular products in small biological 
samples is increasing. Novel natural therapeutics 
development is been promoted using proteins that 
originate from living systems, as this type of therapy will 
provide a more specific and effective treatment, with 
fewer side effects, than conventional drugs. Drug 
discovery is being improved by the use of molecular 
modeling and the development of cell receptor based 
agents. With the discovery that the genes associated with 
cancer are also present in non-humans, there has been 
considerable effort and real promise in using laboratory 

























Despite the controversies surrounding biotechnology and 
the difficulty in arriving on a compromise position, it has 
gained acceptance because there is a consensus that the 
technology provides global opportunity. Biotechnology is 
a tool that provides people the opportunity to better their 
situation; it is something needed to facilitate not impedes 
development. The debate has to shift to the nature of 
innovative policies and law to regulate our adoption of 
this technology. 
As we adopt this technology, we need to have the right 
policies and regulatory framework agencies in place to 
interface and negotiate on our behalf with the big 
multinational companies that have these technologies. 
Check and balances are to be put in place to maintain 
and preserve our local diversity thereby preventing 
foreign companies from patenting our local germplasm; 
policies on intellectual property rights clearly define to 
avoid exploitation of our indigenous scientist, researchers 
and deserving stakeholders. A clearly defined, ambitious 
and well funded sustainable programme for developing 
our indigenous capacity must be in place that will develop 
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